Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients

NCT07405931 is registered in ClinicalTrials.gov with Ulsan University Hospital as lead sponsor.

NCT NCT07405931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07405931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients
Lead sponsor
Ulsan University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
July 9, 2025
Completion date
September 30, 2026
Enrollment
414 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

advanced breast cancer, advanced colon cancer, advanced gastric cancer, advanced lung cancer, early breast cancer, early colon cancer, early gastric cancer, early lung cancer